Pipeline
Pipeline

Jazz’s development pipeline includes the clinical development of new therapies to treat unmet medical needs, line extensions for existing products, and the generation of additional clinical data for existing products.

R&D Pipeline

Pipeline

Updated 11/08/2016

1 NDA submission assumes positive outcomes.
2 JZP-386 formulation work ongoing.
3 The company has made the decision to discontinue development of two early-stage Celator programs, CPX-1 and CPX-8.
ES = Excessive Sleepiness, OSA = Obstructive Sleep Apnea, NDA = New Drug Application, EDS = Excessive Daytime Sleepiness, sNDA = Supplemental New Drug Application, BE = Bioequivalence, EU = European Union, AML = Acute Myeloid Leukemia , VOD = Hepatic Veno-occlusive Disease, HSCT = Hematopoietic Stem Cell Transplantation